Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
City of Hope Medical Center
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
SWOG Cancer Research Network
University of Southern California
Duke University
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)